Lumos Pharma, Inc.
LUMODelisted Dec 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001126234
Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Lumos Pharma, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 36 | 36 | 0 |
| Shares | 2.48M | 2.39M | −93.8K (−3.8%) |
| Value | $23.3M | $18.7M | −$4.60M (−19.7%) |
New holders (4)
Institutions that held Lumos Pharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 21,520 | $166.0K | 0.07% |
| K2 Principal Fund, L.P. | 12,495 | $96.0K | 0.02% |
| Key Financial Inc | 10,916 | $84.0K | 0.05% |
| Urban Wealth Management, LLC | 3,490 | $27.0K | 0.09% |
Sold out (4)
Institutions that held Lumos Pharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 11,339 | $107.0K |
| Paladin Advisory Group, LLC | 4,382 | $40.0K |
| Prospera Financial Services Inc | 1,088 | $10.0K |
| City State Bank | 111 | $1.00K |